Question

I am a breastfeeding mother and i want to know if it is safe to use EINECS 218-171-7? Is EINECS 218-171-7 safe for nursing mother and child? Does EINECS 218-171-7 extracts into breast milk? Does EINECS 218-171-7 has any long term or short term side effects on infants? Can EINECS 218-171-7 influence milk supply or can EINECS 218-171-7 decrease milk supply in lactating mothers?

EINECS 218-171-7 lactation summary

EINECS 218-171-7 is unsafe in breastfeeding
  • DrLact safety Score for EINECS 218-171-7 is 5 out of 8 which is considered Unsafe as per our analyses.
  • A safety Score of 5 indicates that usage of EINECS 218-171-7 may cause serious side effects in breastfed baby.
  • Our study of different scientific research indicates that EINECS 218-171-7 may cause moderate to high side effects or may affect milk supply in lactating mother.
  • Our suggestion is to use safer alternate options rather than using EINECS 218-171-7 .
  • It is recommended to evaluate the advantage of not breastfeeding while using EINECS 218-171-7 Vs not using EINECS 218-171-7 And continue breastfeeding.
  • While using EINECS 218-171-7 Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About EINECS 218-171-7 usage in lactation

Used as treatment of psychosis and Gilles de la Tourette’s syndrome. No data on transfer into breastmilk are available. Sedative effect is likely.

Answer by DrLact: About EINECS 218-171-7 usage in lactation

Because there is no published experience with EINECS 218-171-7 during breastfeeding, other drugs are preferred.

EINECS 218-171-7 Possible Effects in Breastfeeding

EINECS 218-171-7 can cause hyperprolactinemia.[1][2] The hyperprolactinemia is caused by the drug's dopamine-blocking action in the tuberoinfundibular pathway.[3]
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.